Executives/Sanofi CEO
Belén Garijo, CEO of Sanofi

Who is the CEO of Sanofi in 2026?

Belén Garijo is the Chief Executive Officer of Sanofi. Belén has held the CEO seat since May 2026, and was previously Global Vice President Oncology at Aventis Behring.

Updated September 24, 2026
Time in seat
4 months
CEO since May 2026
Years at company
23 years
Joined Sanofi January 2003
Career span
30 years
First recorded role January 1996
Summary
  • Belén Garijo rose through Sanofi: General Manager, Spain from January 2003, then Senior Vice President, Global Operations Region Europe from January 2006, before taking the CEO seat in May 2026.
  • Belén Garijo sits on the board of European Innovation Council and SMEs Executive Agency (EISMEA).
  • Belén Garijo was President & CEO of Biopharma (formerly Merck Serono) at Merck Group from October 2013 to December 2014.

Current company

Sanofi

Sanofi is a French pharmaceutical company.

pharmaceutical industryHeadquartered in ParisFounded 2004Nasdaq: SNY

Source: Wikidata

Career and education

Belén Garijo joined Sanofi in January 2003 and has been CEO since May 2026. Before Sanofi, Belén was Global Vice President Oncology at Aventis Behring from January 2000 until December 2002.

Career

  1. Sanofi2003 to present
    • Chief Executive OfficerMay 2026 to present
    • Senior Vice President, Global Operations Region EuropeJanuary 2006 to December 2010
    • General Manager, SpainJanuary 2003 to December 2005
  2. European Innovation Council and SMEs Executive Agency (EISMEA)2026 to present
    • Board Member
  3. Merck Group2011 to 2026
    • Chair of the Executive Board and CEO of MerckMay 2021 to April 2026
    • Vice Chairman of the Executive Board | Deputy CEOJanuary 2021 to May 2021
    • Vice Chairman of the Executive Board | Deputy CEO | Healthcare CEOJuly 2020 to January 2021
    • CEO Healthcare, Member of the Executive BoardJanuary 2015 to July 2020
    • President & CEO of Biopharma (formerly Merck Serono)October 2013 to December 2014
    • Chief Operating Officer of Biopharma (formerly Merck Serono)January 2011 to September 2013
  4. Aventis Behring2000 to 2002
    • Global Vice President Oncology
  5. Rhone-Poulenc Rorer1996 to 1999
    • Business Unit Director of Oncology

Sources: LinkedIn profile

Education

University of Alcala de Henares, MD, PhD, medical doctor in clinical pharmacologySource

Decision makers by function

2,600+ decision makers at Sanofi in Unify, vice president level and above. Choose a function to see who leads it.

Decision maker preview

Top decision makers at Sanofi

Vice president level and above, most senior first
Audrey CleggChief Talent Officer · FRA@sanofi.com
Jean-Yves Rotté-GeoffroyChief Procurement Officer · FRA@sanofi.com
John SundyChief Medical Officer and Head of R&D · USA@sanofi.com
Jamie HaneyExecutive Vice President and General Counsel · FRA@sanofi.com
See every decision maker at Sanofi

Unlock every decision maker at Sanofi

Get verified profiles, contact data, and live buying signals in Unify.

Leadership team at Sanofi

Belén Garijo leads a leadership team of 12 published executives. The most recent appointment is Manuela Buxo as Executive Vice President, Specialty Care, in seat since March 2026.

Most senior 5 of 12

NameTitleIn seat since
Belén GarijoChief Executive OfficerApril 2026
François RogerExecutive Vice President, Chief Financial OfficerApril 2024
Roy PapatheodorouExecutive Vice President, General CounselNot stated
Emmanuel FrenehardExecutive Vice President, Chief Digital OfficerNot stated
Natalie BickfordExecutive Vice President, Chief People OfficerNot stated

Sources: Sanofi 2025 Form 20-F

Frequently asked questions

Who is the CEO of Sanofi?

Belén Garijo is the Chief Executive Officer of Sanofi. Belén has held the CEO seat since May 2026, and was previously Global Vice President Oncology at Aventis Behring.

When did Belén Garijo become CEO of Sanofi?

Belén Garijo has been CEO of Sanofi since May 2026, according to LinkedIn profile.

What did Belén Garijo do before Sanofi?

Belén Garijo was Global Vice President Oncology at Aventis Behring from January 2000 until December 2002, according to LinkedIn profile.

How long has Belén Garijo been CEO of Sanofi?

Belén Garijo has been CEO of Sanofi for 4 months, since May 2026.

Who else leads Sanofi?

François Roger (Executive Vice President, Chief Financial Officer), Roy Papatheodorou (Executive Vice President, General Counsel), Emmanuel Frenehard (Executive Vice President, Chief Digital Officer), Natalie Bickford (Executive Vice President, Chief People Officer), and 7 more. Source: Sanofi 2025 Form 20-F.

Reach Sanofi's decision makers

2,600+ leaders at vice president level and above, with verified work emails and phone numbers in Unify.

Methodology

The seat holder is identified in Unify's professional profile dataset, then confirmed against the company's published leadership page, its SEC filings, and Wikipedia before publication. Career and education rows carry the public document they were taken from. Leadership team membership follows the company's own leadership page; in-seat dates come from filings where available and otherwise from the profile record. Company figures are read from the Unify headcount page for the same company and are profile coverage measures, never company-reported workforce totals. The employee preview lists vice president and senior vice president level profiles by department. No personal contact details are published.

Identity confirmed against Wikipedia, Sanofi. Last verified: September 24, 2026.